Synthesis of pseudopeptides with sulfoximines as chiral backbone modifying elements

Chemistry - A European Journal

Volumn 7, Issue 5, 2001, Pages 1118-1128

  Bolm, Carsten ^a   Moll, Guido ^a,b   Kahmann, Jan D ^a,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Amino acids; Inhibitors; Peptides; Pseudopeptides; Sulfoximines

Indexed keywords

AMINO ACIDS; CONFORMATIONS; HYDROGEN BONDS; NUCLEAR MAGNETIC RESONANCE; SYNTHESIS (CHEMICAL);

SECONDARY STRUCTURES;

ORGANIC COMPOUNDS;

AMINO ACID; IMINE; PEPTIDE; PSEUDOPEPTIDE; SULFOXIMINE; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; CHEMICAL STRUCTURE; CHIRALITY; CONFORMATION; CYCLIZATION; HYDROGEN BOND; METHODOLOGY; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; STRUCTURE ANALYSIS; SYNTHESIS;

BIOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR MIMICRY; PEPTIDES;

EID: 0035793836     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-3765(20010302)7:5<1118::AID-CHEM1118>3.0.CO;2-3     Document Type: Article

References (154)

1. For peptides in general, see: a) H. D. Jakubke, Peptide, Chemie und Biologie, Spektrum Verlag, Heidelberg, 1996;
2. b) A. Giannis, T. Kolter, Angew. Chem. 1993, 105, 1303;
3. Angew. Chem. Int. Ed. Engl. 1993, 32, 1244;
4. c) J. Gante, Angew. Chem. 1994, 106, 1780;
5. Angew. Chem. Int. Ed. Engl. 1994, 33, 1699.
6. A. E. P. Adang, P. H. H. Hermkens, J. T. M. Linders, H. C. J. Ottenhejim, C. J. vanStaveren, Recl. Trav. Chim. Pays-Bas 1994, 113, 63.
7. For a review on peptide modifications and for the definition of peptidomimetics or peptide mimetics see:M. D. F. Fletcher, M. M. Campbell, Chem. Rev. 1998, 98, 763.
8. J. Rizo, L. M. Gierasch, Annu. Rev. Biochem. 1992, 61, 387.
9. A. Spatola in Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, Vol. 7 (Ed.: B. Weinstein), Marcel Dekker, New York, 1983, pp. 267.
10. For a review about the design of peptide-based drugs, see : A. S. Dutta, Adv. Drug Res. 1991, 33, 1073.
11. D. C. Roberts, F. Vellaccio, in The Peptides: Analysis, Synthesis, Biology, Vol. 5 (Eds.: E. Gross, J. Meienhofer), Academic, New York, 1983, pp. 341.
12. C. Toniolo, Int. J. Pept. Protein Res. 1990, 35, 287.
13. D. P. Fairlie, G. Abbenante, D. R. March, Curr. Med. Chem. 1995, 2, 654.
14. R. Hirschmann, Angew. Chem. 1991, 103, 1305;
15. Angew. Chem. Int. Ed. Engl. 1991, 30, 1278.
16. See for example: K. Burger, M. Kluge, S. Fehn, B. Koksch, L. Hennig, G. Mütter, Angew. Chem. 1999, 111, 1513;
17. Angew. Chem. Int. Ed. 1999, 38, 1414.
18. For a recent example of (E)-olefin dipeptide isosteres see: a) C. E. Masse, B. S. Knight, P. Stavropoulos, J. S. Panek, J. Am. Chem. Soc. 1997, 119, 6040;
19. for aza-dipcptide isosteres as potential HIV-1 protease inhibitors see: b) G. Bold, A. Fässler, H.-G. Capraro, R. Cozens, T. Klimkait, J. Lazdins, J. Mestan, B. Poncioni, J. Rösel, D. Stover, M. Titelnot-Blomley, F. Acemoglu, W. Beck, E. Boss, M. Eschbach, T. Hürlimann, E. Masso, S. Roussel, K. Ucci-Stoll, D. Wyss, M. Lang, J. Med. Chem. 1998, 41, 3387 and references therein;
20. for hydrazinoazapeptoids see: c) A. Cheguillaume, F. Lehardy, K. Bouget, M. Baudy-Floc'h, P. Le Grel, J. Org. Chem. 1999, 64, 2924;
21. for peptoids in general see: d) J. A. W. Kruijtzer, L. J. F. Hofmeyer, W. Heerma, C. Versluis, R. M. J. Liskamp, Chem. Eur. J. 1998, 4, 1570;
22. for an example of β-peptoids see: e) B. C. Hamper, S. A. Kolodziej, A. M. Scates, R. G. Smith, E. Cortez, J. Org. Chem. 1998, 63, 708;
23. for an example of ureapeptoid petidomimetic see: f) J. A. W. Kruijtzer, D. J. Lefeber, R. M. J. Liskamp, Tetrahedron Lett. 1997, 38, 5335;
24. for a peptide/oligourea/azapetide hybrid see: g) M. J. Soth, J. S. Nowick, J. Org. Chem. 1999, 64, 276.
25. a) G. P. Zecchini, M. Paglialunga Paradisi, I. Torrini, G. Lucente, E. Gavuzzo, F. Mazza, G. Pochetti, Tetrahedron Lett. 1991, 32, 6779;
26. b) A. Calcagni, E. Gavuzzo, G. Lucente, F. Mazza, G. Pochetti, D. Rossi, Int. J. Pept. Protein Res. 1989, 34, 319;
27. c) A. Calcagni, E. Gavuzzo, G. Lucente, F. Mazza, F. Pinnen, G. Pochetti, D. Rossi, Int. J. Pept. Protein Res. 1989, 34, 471.
28. a) J. vanAmeijde, R. M. J. Liskamp, Tetrahedron Lett. 2000, 41, 1103;
29. b) D. W. P. M. Löwik, M. D. Weingarten, M. Broekema, A. J. Brouwer, W. C. Still, R. M. J. Liskamp, Angew. Chem. 1998, 110, 1947;
30. Angew. Chem. Int. Ed. 1998, 37, 1846;
31. c) W. J. Moree, G. A. vanderMarcel, R. M. J. Liskamp, J. Org. Chem. 1995, 60, 5157;
32. d) W. J. Moree, L. C. vanGent, G. A. vanderMarcel, R. M. J. Liskamp, Tetrahedron 1993, 49, 1133;
33. e) W. J. Moree, G. A. van der Marcel, R. M. J. Liskamp, Tetrahedron Lett. 1992, 33, 6389;
34. f) W. J. Moree, G. A. van der Marcel, R. M. J. Liskamp, Tetrahedron Lett. 1991, 32, 409;
35. see also: g) S. Paik, E. H. White, Tetrahedron Lett. 1996, 37, 4663.
36. T. L. Sommerfeld, D. Seebach, Angew. Chem. 1995, 107, 622;
37. Angew. Chem. Int. Ed. Engl. 1995, 34, 553.
38. Examples for sulfonamide inhibitors: a) M. T. Pisabarro, A. R. Ortiz, A. Palomer, F. Cabre, L. Garcia, R. C. Wade, F. Gago, D. Mauleon, G. Garganico, J. Med. Chem. 1994, 37, 337;
39. b) K. Hilpert, J. Ackermann, D. W. Banner, A. Gast, K. Gubernator, P. Hadváry, L. Labler, K. Müller, G. Schmid, T. B. Tschopp, H. van der Waterbeemd, J. Med. Chem. 1994, 37, 3889.
40. For transition-state isosteres as inhibitors of various proteases see: J. R. Huff, J. Med. Chem. 1991, 34, 2305.
41. For some examples of transition-state isosteres as inhibitors of HIV-1 proteases see: a) R. C. Reid, D. R. March, M. J. Dooley, D. A. Bergman, G. Abbenante, D. P. Fairlie, J. Am. Chem. Soc. 1996, 118, 8511;
42. b) E. E. Kim, C. T. Baker, M. D. Dwyer, M. A. Murcko, B. G. Rao, R. D. Tung, M. A. Navia, J. Am. Chem. Soc. 1995, 117, 1181;
43. c) B. D. Dorsey, R. B. Levin, S. L. McDaniel, J. P. Vacca, J. P. Guare, P. L. Darke, J. A. Zugay, E. A. Emini, W. A. Schleif, J. C. Quintero, J. H. Lin, I.-W. Chen, M. K. Holloway, P. M. D. Fitzgerald, M. G. Axel, D. Ostovic, P. S. Anderson, J. R. Huff, J. Med. Chem. 1994, 37, 3443.
44. For a theoretical investigation of phosphonamidates and sulfonamides as protease transition-state isosteres see: J. L. Radkiewicz, M. A. McAllister, E. Goldstein, K. N. Houk, J. Org. Chem. 1998, 63, 1419.
45. For phosphonamidates as inhibitors see: a) B. P. Morgan, J. M. Scholtz, M. D. Ballinger, I. D. Zipkin, P. A. Bartlett, J. Am. Chem. Soc. 1991, 113, 297;
46. b) P. A. Bartlett, C. K. Marlow, Biochemistry 1987, 26, 8553;
47. c) K. A. Mookhtiar, C. K. Marlow, P. A. Bartlett, H. E. Van Wart, Biochemistry 1987, 26, 1962;
48. d) E. N. Jacobsen, P. A. Bartlett, J. Am. Chem. Soc. 1981, 103, 654.
49. α-Amino sulfonamides undergo spontaneous fragmentation: a) D. Merricks, P. G. Sammes, E. R. H. Walker, K. Henrick, M. M. MacPartlin, J. Chem. Soc., Perkin Trans. 1 1991, 2169;
50. b) W. F. Gilmore, H.-J. Lin, J. Org. Chem. 1978, 43, 4535;
51. c) M. Frankel, P. Moses, Tetrahedron 1960, 9, 289;
52. d) L. Neelakantan, W. H. Hartung, J. Org. Chem. 1959, 24, 1943.
53. M. Gude, U. Piarulli, D. Potenza, B. Salom, C. Gennari, Tetrahedron Lett. 1996, 37, 8589.
54. For the use of sulfonamides in molecular tweezers see: a) A. J. Brouwer, H. J. van den Linden, R. M. J. Liskamp, J. Org. Chem. 2000, 65, 1750;
55. b) D. W. P. M. Löwik, M. D. Weingarten, M. Broekema, A. J. Brouwer, W. C. Still, R. M. J. Liskamp, Angew. Chem. 1998, 110, 1947;
56. Angew. Chem. Int. Ed. 1998, 57, 1846.
57. For nine-membered rings built by intramolecular hydrogen bonds in β-sulfonamide dipeptides see: C. Gennari, M. Gude, D. Potenza, U. Piarulli, Chem. Eur. J. 1998, 4, 1924.
58. a) C. Gennari, C. Longari, S. Ressel, B. Salom, U. Piarulli, S. Ceccarelli, A. Mielgo, Eur. J. Org. Chem. 1998, 2437;
59. b) C. Gennari, B. Salom, D. Potenza, C. Longari, E. Fiovaranzo, O. Carugo, N. Sardone, Chem. Eur. J. 1996, 2, 644;
60. c) C. Gennari, H. P. Nestler, B. Salom, W. C. Still, Angew. Chem. 1995, 107, 1892;
61. Angew. Chem. Int. Ed. Engl. 1995, 34, 1763;
62. d) C. Gennari, B. Salom, D. Potenza, A. Williams, Angew. Chem. 1994, 106, 2181;
63. Angew. Chem. Int. Ed. Engl. 1994, 33, 2061.
64. For reviews on sulfoximines see: a) S. G. Payne, Sulfur Rep. 1992, 12, 57;
65. b) C. R. Johnson, Aldrichim. Acta 1985, 18, 3;
66. c) C. R. Johnson, Acc. Chem. Res. 1973, 6, 341;
67. d) C. R. Johnson in Comprehensive Organic Chemistry (Eds.: D. Barton, W. D. Ollis), Pergamon Press, Oxford, 1979;
68. e) M. Reggelin, C. Zur, Synthesis 2000, 1.
69. a) W. L. Mock, J. Z. Zhang, J. Org. Chem. 1990, 55, 5791;
70. b) W. L. Mock, J. T. Tsay, J. Am. Chem. Soc. 1989, 111, 4467;
71. c) W. L. Mock, J. Z. Zhang, J. Biol. Chem. 1991, 260, 6393;
72. d) see also: W. L. Mock, J. T. Tsay, Synth. Commun. 1988, 18, 769.
73. P. D. Kennewell, J. B. Taylor, Chem. Soc. Rev. 1975, 4, 189.
74. R. G. Laughlin, W. Yellin, J. Am. Chem. Soc. 1967, 89, 2435.
75. For some recent applications of sulfoximines see: a) C. Bolm, J. P. Hildebrand, J. Org. Chem. 2000, 65, 169;
76. b) C. Bolm, K. Muñiz, N. Aguilar, M. Kesselgruber, G. Raabe, Synthesis 1999, 1251;
77. c) C. Bolm, J. P. Hildebrand, Tetrahedron Lett. 1998, 39, 5731;
78. d) C. Bolm, J. P. Hildebrand, J. Rudolph, Synthesis 2000, 911;
79. e) M. Reggelin, T. Heinrich, Angew. Chem. 1998, 110, 3005;
80. Angew. Chem. Int. Ed. 1998, 37, 2883;
81. f) S. Boßhammer, H.-J. Gais, Synthesis 1998, 919;
82. g) J. Hachtel, H.-J. Gais, Eur. J. Org. Chem. 2000, 1457;
83. h) S. G. Pyne, Z. Dong, B. W. Skelton, A. H. White, J. Org. Chem. 1997, 62, 2337;
84. i) for a recent application of sulfoximines in natural product synthesis see: L. A. Paquette, Z. Gao, Z. Ni, G. F. Smith, J. Am. Chem. Soc. 1998, 120, 2543.
85. For applications as ligands see: a) C. Bolm, D. Kaufmann, M. Zehnder, M. A. Neuburger, Tetrahedron Lett. 1996, 37, 3985;
86. b) C. Bolm, P. Müller, Acta Chem. Scand. 1996, 50, 305;
87. c) C. Bolm, P. Müller, Tetrahedron Lett. 1995, 36, 1625;
88. d) C. Bolm, M. Felder, Synlett 1994, 655;
89. e) C. Bolm, A. Seger, M. Felder, Tetrahedron Lett. 1993, 34, 8079;
90. f) C. Bolm, J. Müller, G. Schlingloff, M. Zehnder, M. A. Neuburger, J. Chem. Soc. Chem. Commun. 1993, 182;
91. g) C. Bolm, M. Felder, Tetrahedron Lett. 1993, 34, 6041;
92. h) C. Bolm, M. Felder, J. Müller, Synlett 1992, 439;
93. 2-symmetric bis-sulfoximine see: C. Bolm, F. Bienewald, K. Harms, Synlett 1996, 775.
94. S. Poenaru, J. R. Lamas, G. Folkers, J. A. López de Castro, D. Seebach, D. Rognan, J. Med. Chem. 1999, 42, 2318.
95. a) J. J. Barchi Jr., X. Huang, D. H. Apella, L. A. Christianson, S. R. Durell, S. H. Gellman, J. Am. Chem. Soc. 2000, 122, 2711;
96. b) S. Abele, K. Vögtli, D. Seebach, Helv. Chim. Acta 1999, 82, 1539;
97. c) S. H. Gellman, Acc. Chem. Res. 1998, 31, 173;
98. d) D. Seebach, J. L. Matthews, Chem. Commun. 1997, 2015;
99. e) S. Borman, Chem. Eng. News 1997, June 16, 32 and references therein;
100. f) B. L. Iverson, Nature 1997, 385, 113;
101. g) B. R. Huck, J. M. Langenhan, S. H. Gellman, Org. Lett. 1999, 1, 1717;
102. for biological studies on β-peptides see: h) K. Gademann, M. Ernst, D. Seebach, Helv. Chim. Acta 2000, 83, 16;
103. i) K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302;
104. Angew. Chem. Int. Ed. 1999, 38, 1223;
105. j) D. Seebach, S. Abele, J. V. Schreiber, B. Martinoni, A. K. Nussbaum, H. Schild, H. Schulz, H. Hennecke, R. Wössner, F. Bitsch, Chimia 1998, 52, 734;
106. k) T. Hintermann, D. Seebach, Chimia 1997, 51, 244;
107. l) U. Koert, Angew. Chem. 1997, 109, 1836;
108. Angew. Chem. Int. Ed. Engl. 1997, 56, 1836;
109. for a review on the synthesis of β-amino acids see: m) S. Abele, D. Seebach, Eur. J. Org. Chem. 2000, 1.
110. a) C. R. Johnson, C. W. Schroeck, J. Am. Chem. Soc. 1973, 95, 7418;
111. b) R. Fusco, F. Tericoni, Chem. Ind. (Milano) 1965, 47, 61.
112. For the synthesis by stereospecific imination of sulfoxides using MSH see: a) G. Boche in Reagents in Organic Synthesis (Ed.: L. Paquette), Wiley, New York, 1995, pp. 3277;
113. b) C. R. Johnson, R. A. Kirchoff, H. G. Corkins, J. Org. Chem. 1974, 39, 2458;
114. c) Y. Tamura, J. Minamikawa, K. Sumoto, S. Fujii, M. Ikeda, J. Org. Chem. 1973, 38, 1239.
115. 3 see: a) J. F. K. Müller, P. Vogt, Tetrahedron Lett. 1998, 39, 4805;
116. b) T. Bach, C. Körber, Eur. J. Org. Chem. 1999, 1033;
117. c) T. Bach, C. Körber, Tetrahedron Lett. 1998, 39, 5015;
118. d) C. Bolm, J. P. Hildebrand, unpublished results.
119. For an efficient resolution see:H.-J. Gais, J. Brandt, Tetrahedron: Asymmetry 1997, 8, 909.
120. Preliminary communication: C. Bolm, J. D. Kahmann, G. Moll, Tetrahedron Lett. 1997, 38, 1169.
121. J. D. Kahmann, Diplomarbeit, Philipps-Universität Marburg, Germany, 1995.
122. The Boc-protected amino acids were chosen because the protecting group can be easily cleaved using TFA. (Boc=tert-butyloxycarbonyl, TFA=trifluoroacetic acid).
123. Based on the results of a solid state structure analysis by X-ray crystallography of an acylated sulfoximine in J. Müller, Dissertation, Universität Basel, Switzerland, 1993, we assume that the pseudopeptides adopt a prefered cis-orientation at the OC-NS bond.
124. a) M. Bodanzky, Principles of Peptides Synthesis, Springer, Berlin, 1993;
125. b) J. Jones, Synthese von Aminosäuren und Peptiden, VCH, Weinheim, 1996.
126. HOBt=1-hydroxybenzotriazole, DCC=dicyclohexylcarbodiimide, PyBOP=(benzotriazole-1-yl-oxy)-tris(pyrrolidino)phosphonium hexafluorophosphate; DIEA=N,N(diisopropyl)ethylamine.
127. The same integration ratio was observed for the doublets of the diastereomeric methyl groups of the amino acid side chain.
128. a) D. Seebach, Aldrichim. Acta 1992, 25, 59;
129. b) D. Seebach, Angew. Chem. 1988, 100, 1685;
130. Angew. Chem. Int. Ed. Engl. 1988, 27, 1624;
131. c) D. Seebach, A. K. Beck, A. Studer, in Modern Synthetic Methods, Vol. 7 (Eds.: B. Ernst, C. Leumann), VCH, Weinheim, 1995; pp. 1.
132. See also: K. Schaffner-Sabba, H. Tomaselli, B. Henrici, H. B. Renfroe, J. Org. Chem. 1977, 42, 952.
133. For the synthesis of other α-sulfonimidoyl carboxy derivatives using different bases see: a) K.-J. Hwang, J. Org. Chem. 1986, 51, 99;
134. b) C. Bolm, M. Zehnder, J. Müller, M. A. Neuburger, Chem. Eur. J. 1995, 1, 312.
135. 2 see: D. J. Cram, J. Org. Chem. 1973, 38, 20.
136. It is very important to perform the carboxylation under rigorous exclusion of moisture, because otherwise the desired ammonium carboxylates are not obtained in good yields.
137. 1H NMR spectroscopy revealed that the purity of the products was about 85%. The impurities are cyclohexyl(isopropyl)amine and unreacted starting material which has not been carboxylated.
138. a) G. Moll, Dissertation, RWTH Aachen, Germany, 1999; further details will be published in due course .
139. For a review on allylic protecting groups and their removal using palladium see: a) F. Guibé, Tetrahedron 1998, 54, 2967;
140. b) H. Kunz, H. Waldmann, Angew. Chem. 1984, 96, 49;
141. Angew. Chem. Int. Ed. Engl. 1984, 23, 71.
142. a) C. Bolm, M. Felder, J. Müller, Synlett 1992, 439;
143. M. Felder, Dissertation, Philipps-Universität Marburg, Germany, 1995.
144. In the solid state an intramolecular hydrogen bond between the amide proton and the sulfoximine oxygen has been found in a β-hydroxy sulfoximine. M. Reggelin, H. Weinberger, M. Gerlach, R. Welcker, J. Am. Chem. Soc. 1996, 118, 4765.
145. a) D. Yang, J. Qu, B. Li, F.-F. Ng, X.-C. Wang, K.-K. Cheung, D.-P. Wang, Y.-D. Wu, J. Am. Chem. Soc. 1999, 121, 589;
146. b) D. Yang, F.-F. Ng, Z.-J. Li, Y.-D. Wu, K. W. K. Chan, D.-P. Wang, J. Am. Chem. Soc. 1996, 118, 9794;
147. c) Y.-D. Wu, D.-P. Wang, K. W. K. Chan, D. Yang, J. Am. Chem. Soc. 1999, 121, 11189.
148. a) L. Belvisi, C. Gennari, A. Mielgo, D. Potenza, C. Scolastico, Eur. J. Org. Chem. 1999, 389;
149. See also: b) J. Yang, S. H. Gellman, J. Am. Chem. Soc. 1998, 120, 9090;
150. c) I. G. Jones, W. Jones, M. North, J. Org. Chem. 1998, 63, 1505;
151. d) S. H. Gellman, G. P. Dado, G.-B. Liang, B. R. Adams, J. Am. Chem. Soc. 1991, 113, 1164;
152. e) S. H. Gellman, B. R. Adams, Tetrahedron Lett. 1989, 30, 3381;
153. f) E. S. Stevens, N. Sugawara, G. M. Bonora, C. Toniolo, J. Am. Chem. Soc. 1980, 102, 7048.
154. S)-N-tert-butyloxycarbonyl S-methyl S-tolyl sulfoximine see: M. Reggelin, Dissertation, Uiversität Kiel, Germany, 1989.